Clinical Trials Directory

Trials / Unknown

UnknownNCT04787497

The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis

The Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple Sclerosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
University of Cyprus · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is an open label feasibility trial to examine the effect of a complementary treatment with High Phenolic Extra Virgin Olive Oil (HPEVOO) on the cognitive and mental health of people with Multiple Sclerosis (MS), while receiving their standard medical treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHigh Phenolic Extra Virgin Olive OilParticipants will be assigned in two groups: the Experimental Group (N= 20) will be receiving 50ml of freshly, cold-pressed, oleocanthal-rich Extra Virgin Olive Oil (EVOO) alongside their prescribed medical treatment, whereas the Control Group (N = 20) will be receiving their medical treatment as usual. The Experimental Group will be receiving the complementary treatment on a daily basis for 12 months and all participants will undergo a neuropsychological assessment at baseline, 6 months and 12 months +/- 7 days after their first assessment or beginning of treatment.

Timeline

Start date
2022-05-01
Primary completion
2024-05-01
Completion
2024-09-01
First posted
2021-03-08
Last updated
2023-11-02

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04787497. Inclusion in this directory is not an endorsement.